Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury
NCT ID: NCT07119827
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2025-05-01
2028-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary aims are to assess the effects of premorbid personality on the sort- and long-term recovery in autonomy (disability), cognitive functions, psycho-behavioral functioning, motor skills, and social participation. Evaluate the incidence of premorbid personality alterations. Investigate personality changes 12-18 months after the neurological event.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Brain Connectome and Personality on Cognitive Rehabilitation in Multiple Sclerosis
NCT03306875
Acquired Brain Injury and Neurorehabilitation: the Influence of Psychological Characteristics
NCT06661512
Effects of Telerehabilitation on Brain Network Connectivity
NCT06278818
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
NCT05157880
Efficacy of Multidimensional Management of Mild Traumatic Brain Injury
NCT03811626
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
T0: Initial assessment upon admission to the rehabilitation facility; within 90 days of the event for patients with severe acquired brain injury (sABI), as soon as cognitive evaluation becomes feasible (LCF ≥ 6); within 30 days of the event for stroke patients, as soon as cognitive assessment is possible.
T1: At discharge from the inpatient rehabilitation program, provided that at least 30 days have passed since the initial assessment (T0).
T2: At 12 months post-event for stroke patients and at 18 months post-event for patients with ABI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic or hemorrhagic stroke
Aged between 18 and 80 years; ischemic or hemorrhagic stroke without features of severe acquired brain injury (Glasgow Coma Scale ≥ 8 and no alteration in consciousness); time from onset between 3 and 30 days
Motor, cognitive and psychological assessment
Participants evaluated at T0 (Initial assessment upon admission to the rehabilitation facility), T1 (at discharge from the inpatient rehabilitation program, as long as at least 30 days have passed since the initial assessment (T0), T2 (at 12 months from the event for patients with stroke, and at 18 months from the event for patients with sABI).
Severe Acquired Brain Injury (sABI) of traumatic or non-traumatic etiology
Aged between 18 and 80 years; severe Acquired Brain Injury (sABI) of traumatic or non-traumatic etiology meaning that the patient initially presents with a state of coma (Glasgow Coma Scale score \< 8) accompanied by simultaneous motor, sensory, cognitive and/or behavioral impairment; Glasgow Coma Scale ≥ 8 and no alteration in consciousness; time from onset between 7 and 90 days; Level of Cognitive Functioning (LCF) \>=6
Motor, cognitive and psychological assessment
Participants evaluated at T0 (Initial assessment upon admission to the rehabilitation facility), T1 (at discharge from the inpatient rehabilitation program, as long as at least 30 days have passed since the initial assessment (T0), T2 (at 12 months from the event for patients with stroke, and at 18 months from the event for patients with sABI).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motor, cognitive and psychological assessment
Participants evaluated at T0 (Initial assessment upon admission to the rehabilitation facility), T1 (at discharge from the inpatient rehabilitation program, as long as at least 30 days have passed since the initial assessment (T0), T2 (at 12 months from the event for patients with stroke, and at 18 months from the event for patients with sABI).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe Acquired Brain Injury (sABI) of traumatic or non-traumatic etiology; the term sABI includes acute brain injuries of traumatic or non-traumatic origin (vascular, infectious, metabolic, or anoxic), in which the patient initially presents with a coma state (Glasgow Coma Scale - GCS less than 8) and simultaneously exhibits motor, sensory, cognitive, and/or behavioral impairments.
* Ischemic or hemorrhagic stroke without features of Severe Acquired Brain Injury (sABI) (Glasgow Coma Scale \[GCS\] score ≥ 8 and no alteration of consciousness).
* Time from injury between:
* 7 and 90 days for Severe Acquired Brain Injury (sABI) patients
* 3 and 30 days for stroke patients
* Level of Cognitive Functioning (LCF) score ≥ 6 for sABI patients
* Signed informed consent for study participation
* Presence of a support family member (caregiver) able to assist with completing the personality questionnaire (HEXACO Adjective Scale, HAS)
Exclusion Criteria
* Severe aphasia or severe inattention that precludes administration of the tests required by the protocol, as identified during cognitive screening.
* Patients with a language barrier due to insufficient proficiency in Italian.
* Particularly vulnerable populations:
The following patients will be excluded from the study: patients in emergency situations.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CRT Montevarchi (Arezzo), Dr. Benedetta Basagni
UNKNOWN
Azienda USL Toscana Sud Est
OTHER_GOV
Centro Cardinal Ferrari, Fontanellato, Parma
UNKNOWN
Montecatone Rehabilitation Institute S.p.A., Imola (Italy)
UNKNOWN
Fondazione IRCCS Santa Lucia, Roma, Italy
UNKNOWN
IRCCS Fondazione Don Carlo Gnocchi, Milano
UNKNOWN
Azienda Unita Sanitaria Locale di Piacenza, Italy
UNKNOWN
Azienda Sanitaria dell'Alto Adige
OTHER
Azienda Ospedaliero, Universitaria Pisana
OTHER
Azienda Sanitaria Locale CN1 Cuneo
OTHER_GOV
Istituto S.Anna Crotone
UNKNOWN
Dr. Navarro Solano Jorghe, MD of the Fondazione Don Carlo Gnocchi Onlus Santa Maria Nascente center
UNKNOWN
Dr. Pasqualone Eugenia MD Fondazione Don Carlo Gnocchi Onlus of La Spezia center
UNKNOWN
SO Riabilitazione Neuromotoria, IRCCS Fondazione Don Carlo Gnocchi (Firenze) - Francesca Cecchi
UNKNOWN
SO Riabilitazione GCA, IRCCS Fondazione Don Carlo Gnocchi (Firenze) - Bahia Hakiki
UNKNOWN
Universita di Verona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valentina Varalta
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sezione medicina fisica e riabilitativa dipartimento di neuroscienze, verona
Verona, VR, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
481CET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.